What Drove Ctrip’s Packaged Tour Business In Q2 2016?
Ctrip’s packaged tour business increased by 34% y-o-y to reach over $71 million in Q2 2016.
- There has been an increasing demand for custom made tours within Ctrip’s packaged tour business. The rise in spending power is propelling Chinese travelers towards personalized travel experiences. Ctrip’s packaged tour business was primarily driven by the customized tour offerings.
- Ctrip’s alliance with Shanghai Disney Resort is also providing a great boost to its packaged tour business, with the Chinese OTA leaders selling over 10,000 tickets on peak days. This was significant considering the resort just opened a couple of months ago.
- Offline, Ctrip further grew its partnerships with its key partners. It also signed a strategic agreement with Beijing Tourism Group, a travel conglomerate.
Ctrip’s packaged tour business is expected to grow at a CAGR of ~17% between 2016 to 2022, the same rate at which the entire business is expected to grow.
Have more questions about Ctrip? See the links below.
- What Is Ctrip’s Revenue And EBITDA Breakdown?
- How Has Ctrip’s Revenue And EBITDA Composition Changed Over 2012-2016E?
- Ctrip Q4 2015 Pre-Earnings Report
- What Drove Ctrip’s Revenue Growth And Led To Its EBITDA Decline Over The Last Five Years?
- Ctrip: Year 2015 In Review
- Ctrip Q1 2016 Earnings Preview
- Where Can Ctrip’s Growth Come From In The Next 5 Years?
- Which Two Segments Are The Biggest Contributors To Ctrip’s Growth?
- How Fast Is Ctrip’s Hotel Revenue Growing?
- How Can Ctrip’s Expansion In Geographies Like The U.S. Impact Its Share Price?
- How Did The Brexit Decision Impact Ctrip So Far?
- Ctrip Q2 2016 Earnings Preview
- Ctrip Continues Growing Though Its Bottom Line Remained Dampened Due To Investments
Notes:
- IQOS Helps Philip Morris Navigate Well In Q1
- Down 45% Year To Date, What’s Happening With Sirius Stock?
- Meta Platforms Stock Dropped 10.6% In A Day, What’s Next?
- What Factors Will Drive Pfizer’s Q1 Performance?
- A Rebound In Asia Travel Will Likely Drive Estée Lauder’s Q3 Performance
- Higher Medical Costs Likely Weighed On CVS Health’s Q1 Earnings
See More at Trefis | View Interactive Institutional Research (Powered by Trefis)